|
DSN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.923200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.702800E-03 |
| Normal-vs-Stage2 |
3.252200E-01 |
| Normal-vs-Stage3 |
7.176300E-02 |
| Normal-vs-Stage4 |
5.433400E-01 |
| Stage1-vs-Stage2 |
3.279800E-01 |
| Stage1-vs-Stage3 |
5.068400E-01 |
| Stage1-vs-Stage4 |
1.729790E-01 |
| Stage2-vs-Stage3 |
6.623600E-01 |
| Stage2-vs-Stage4 |
7.757200E-01 |
| Stage3-vs-Stage4 |
4.444200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.015940E-02 |
| Normal-vs-AfricanAmerican |
1.428840E-01 |
| Normal-vs-Asian |
4.023600E-02 |
| Caucasian-vs-AfricanAmerican |
6.673000E-01 |
| Caucasian-vs-Asian |
5.788000E-01 |
| AfricanAmerican-vs-Asian |
9.902000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.436000E-02 |
| Normal-vs-Female |
2.070100E-02 |
| Male-vs-Female |
4.974200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.566900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.088160E-01 |
| Normal-vs-Age(61-80Yrs) |
9.411800E-02 |
| Normal-vs-Age(81-100Yrs) |
9.487200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.493800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.049800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.974410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.007800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.406200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.795200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.037900E-02 |
| Classical-VS-Follicular |
6.129000E-01 |
| Classical-VS-Other |
1.317230E-01 |
| Classical-VS-Normal |
2.095600E-03 |
| Tall-VS-Follicular |
2.439200E-01 |
| Tall-VS-Other |
4.987800E-01 |
| Tall-VS-Normal |
8.404000E-01 |
| Follicular-VS-Other |
3.167400E-01 |
| Follicular-VS-Normal |
1.005840E-01 |
| Other-VS-Normal |
4.658400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.855900E-03 |
| Normal-vs-N1 |
5.448600E-01 |
| N0-vs-N1 |
1.972650E-01 |
|
|
